| Company: | Vanda Pharmaceuticals, Inc |
| Ticker Symbol: | VNDA |
| Class Period: | Dec-18-12 to Jun-18-13 |
| Date Filed: | Jun-26-13 |
| Lead Plaintiff Deadline: | Aug-25-13 |
| Court: | District of Columbia |
| Allegations: | |
The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is December 18, 2012 through June 18, 2013.
Plaintiff seeks to recover damages on behalf of all Vanda Pharmaceuticals, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.
